During the past decade, New York Medical College/Bradhurst Building conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York Medical College/Bradhurst Building" #1 collaborator was "Lundbeck LLC" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "New York Medical College/Bradhurst Building" are "Postural Tachycardia Syndrome" (2 trials), "Fainting" (1 trials), "Orthostatic Intolerance" (1 trials), "POTS" (1 trials) and "Postural Orthostatic Tachycardia Syndrome (POTS)" (1 trials). Many other conditions were trialed in "New York Medical College/Bradhurst Building" in a lesser frequency.

Most popular intervention types in "New York Medical College/Bradhurst Building" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Ascorbic Acid (Vitamin C)" (1 trials), "Digoxin" (1 trials), "L-Ng-monomethyl Arginine (L-NMMA)" (1 trials) and "Losartan" (1 trials). Other intervention names were less common.

The vast majority of trials in "New York Medical College/Bradhurst Building" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "New York Medical College/Bradhurst Building". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in New York Medical College/Bradhurst Building, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in New York Medical College/Bradhurst Building, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".